Marinomed Biotech AG

Director's Dealing • Oct 18, 2019

Publication Date: 18.10.2019 17:00 EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR)

Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

personal data:
responsible party:
name: aws Mittelstandsfonds Beteiligungs GmbH & Co KG (legal person)
--------------------------------------------------------------------------------
reason:
reason: responsible party is a legal person associate to a person with
managerial responsibilities
name and surname: Mag.(FH) Karl Lankmayr
function: Member of an administrative or supervisory board
--------------------------------------------------------------------------------
issuer information:
name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405
--------------------------------------------------------------------------------
information about deal:
ISIN: ATMARINOMED6
description of the financial instrument: share
type: disposition
date: 16.10.2019; UTC+02:00
market: Outside the trading venue
currency: Euro
 price volume
 EUR 95.00 57,500
total volume: 57,500
total price: EUR 5,462,500
average price: EUR 95,00

---

Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at end of announcement euro adhoc

---

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

Further inquiry note:

Aussendung übermittelt durch euro adhoc
The European Investor Relations Service